Mark D. Plinio - 14 Jun 2021 Form 3 Insider Report for Evelo Biosciences, Inc.

Role: Chief Commercial Officer
Signature: /s/ Daniel S. Char, Attorney-in-Fact for Mark D. Plinio
Issuer symbol: EVLO on OTC
Transactions as of: 14 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 16 Jun 2021, 16:14:16 UTC
Next filing: 21 Jan 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney